Clinical trial
Comparison of Anesthetic Quality and Recovery Between Afentanil and Remifentanil: A Multicenter, Randomized, Double-Blind, Controlled, Non-Inferiority Trial
NCT07761312 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Anesthetic Quality and Recovery Between Afentanil and Remifentanil: A Multicenter, Randomized, Double-Blind, Controlled, Non-Inferiority Trial
- Lead sponsor
- Qianfoshan Hospital
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- September 30, 2027
- Enrollment
- 990 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anesthesia recovery period ; postoperative pain; hemodynamic stability during surgery